Explore our latest breakthroughs in Esophageal Cancer Research. Learn more about our innovative pipeline today! @ Esophageal ...

Celldex has stopped development of barzolvolimab in eosinophilic esophagitis (EoE) despite meeting its primary endpoint in a ...

Although gastrointestinal stromal tumor, or GIST, is a rare type of cancer, between 4,000 and 6,000 people are diagnosed with ...

Dr. Rosario Ligresti discussed common signs and symptoms of GIST, as well as highlighted how the treatment landscape has ...

This clinical study update could impact AstraZeneca’s stock performance positively by showcasing its commitment to innovative cancer treatments. Investors may view this as a strategic move to ...

Enforcement of universal screenings would easily prevent sickness, expenses and death but enforcement isn’t easy.

University of Warwick researchers have built a new diamond-based magnetic field sensor that could be used to better find ...

Detailed price information for Alx Holdings Inc (ALXO-Q) from The Globe and Mail including charting and trades.

PD-1 inhibitors are projected to dominate future drug sales. Immuno-oncology therapies, particularly the PD-(L)1 class, have revolutionized cancer ca ...

Esophageal carcinoma (EC) is a tumor type of the digestive tract that accounts for about 300,000 deaths worldwide annually, with high aggressiveness and poor prognosis. Chinese researchers have ...

ALX hopes to gain insights by tracking EGFR expression in a new trial of ALX2004 and to identify best responders using CD47 expression in a trial of evorpacept.